Avinger Inc

NASDAQ:AVGRUnited States

NASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)

Avinger, Inc. is a commercial-stage medical device company. The Company designs, manufactures, and sells real-time, image-guided, minimally invasive catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). Its Lumivascular platform includes the Lightbox real-time imaging console, the Ocelot and Tigereye family of catheters, which are image-guided catheters designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and the Pantheris family of catheters, its image-guided atherectomy family of catheters designed to allow physicians to remove arterial plaque in PAD patients. Its Pantheris is a single-use product and provides physicians with the ability to see a cross-sectional view of the peripheral artery to guide the removal of blockages throughout the procedure. It has also developed a line extension of its Pantheris image-guided atherectomy platform, Pantheris Small Vessel (SV).

Contact Information

Headquarters

400 Chesapeake DrREDWOOD CITY, CA, United States 94063-4739

Phone

650-363-2400

Fax

302-655-5049

Executives

Non-Executive Independent Chairman of the Board

James Cullen

President, Chief Executive Officer, Director

Jeffrey Soinski

Chief Financial Officer, Chief Accounting Officer, Vice President - Finance

Nabeel Subainati

Chief Technology Officer

Himanshu Patel

Director

Zhong Zhao